Interestingly, we observed that increased SETD2 expression was accompanied by enhanced GATA3 expression in Treg cells in cancerous tissues from colorectal cancer (CRC) patients compared with noncancerous colorectal tissues (Fig. 6k–n). Here, SETD2 is linked to colorectal cancer.